Cargando…

Blockade of HVEM for Prostate Cancer Immunotherapy in Humanized Mice

SIMPLE SUMMARY: Current immune checkpoint inhibitors have shown limitations for immunotherapy of prostate cancer. Thus, it is crucial to investigate other immune checkpoints to prevent disease progression in patients with prostate cancer. Here, we first show that the HVEM/BTLA immune checkpoint is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aubert, Nicolas, Brunel, Simon, Olive, Daniel, Marodon, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235544/ https://www.ncbi.nlm.nih.gov/pubmed/34208480 http://dx.doi.org/10.3390/cancers13123009

Ejemplares similares

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
por: Demerlé, Clemence, et al.
Publicado: (2021)

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model
por: Burlion, Aude, et al.
Publicado: (2017)

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
por: Demerlé, Clémence, et al.
Publicado: (2023)

A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system
por: Burlion, Aude, et al.
Publicado: (2019)

HVEM Signalling Promotes Colitis
por: Schaer, Corinne, et al.
Publicado: (2011)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Publicado: (2023)

Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses
por: Spodzieja, Marta, et al.
Publicado: (2017)

Radiotherapy-Related Gene Signature in Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2022)

LIGHT–HVEM signaling in keratinocytes controls development of dermatitis
por: Herro, Rana, et al.
Publicado: (2018)

Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding
por: Spodzieja, Marta, et al.
Publicado: (2020)

Virtual Evolution of HVEM Segment for Checkpoint Inhibitor Discovery
por: Yu, Mingjia, et al.
Publicado: (2021)

HVEM Gene Polymorphisms Are Associated with Sporadic Breast Cancer in Chinese Women
por: Li, Dalin, et al.
Publicado: (2013)

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis
por: Lan, Xiuwen, et al.
Publicado: (2017)

High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma
por: Ma, Bingqi, et al.
Publicado: (2021)

A crucial role for HVEM and BTLA in preventing intestinal inflammation
por: Steinberg, Marcos W., et al.
Publicado: (2008)

Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032
por: Kogionou, Paraskevi, et al.
Publicado: (2023)

HIV Replication Is Not Controlled by CD8(+) T Cells during the Acute Phase of the Infection in Humanized Mice
por: Petit, Nicolas Y., et al.
Publicado: (2015)

Modulation of LIGHT-HVEM Costimulation Prolongs Cardiac Allograft Survival
por: Ye, Qunrui, et al.
Publicado: (2002)

Nectin-1 and HVEM: cellular receptors for HSV-1 in skin
por: Knebel-Mörsdorf, Dagmar
Publicado: (2016)

Attenuation of the BTLA/HVEM Regulatory Network in the Circulation in Primary Sjögren’s Syndrome
por: Small, Annabelle, et al.
Publicado: (2022)

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2023)

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
por: Wada, Satoshi, et al.
Publicado: (2013)

HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma
por: Malissen, Nausicaa, et al.
Publicado: (2019)

HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage
por: Muscate, Franziska, et al.
Publicado: (2018)

HVEM is a TNF Receptor with Multiple Regulatory Roles in the Mucosal Immune System
por: Shui, Jr-Wen, et al.
Publicado: (2014)

LCMV induced downregulation of HVEM on antiviral T cells is critical for an efficient effector response
por: Diethelm, Patrizia, et al.
Publicado: (2022)

Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
por: Youlin, Kuang, et al.
Publicado: (2012)

Knockdown of HVEM, a Lymphocyte Regulator Gene, in Ovarian Cancer Cells Increases Sensitivity to Activated T Cells
por: Zhang, Ting, et al.
Publicado: (2016)

HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160
por: Liu, Weifeng, et al.
Publicado: (2021)

Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM
por: Zhu, Yuwen, et al.
Publicado: (2016)

The BTLA–HVEM–CD5 Immunoregulatory Axis–An Instructive Mechanism Governing pTreg Cell Differentiation
por: Bourque, Jessica, et al.
Publicado: (2019)

BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection
por: Yu, Xueping, et al.
Publicado: (2019)

BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2021)

TGFβ: Signaling Blockade for Cancer Immunotherapy
por: Chen, Szu-Ying, et al.
Publicado: (2022)

The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis
por: Yang, Bin, et al.
Publicado: (2016)

Application of PD-1 Blockade in Cancer Immunotherapy
por: Wu, Xiaomo, et al.
Publicado: (2019)

Human Cancer Immunotherapy with PD-1/PD-L1 Blockade
por: Zheng, Peilin, et al.
Publicado: (2015)

In situ transduction of stromal cells and thymocytes upon intrathymic injection of lentiviral vectors
por: Marodon, Gilles, et al.
Publicado: (2004)

HVEM tomography of the trans-Golgi network: structural insights and identification of a lace-like vesicle coat
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_a5jknhjug8dbsfu9skfeo3lc5g